Delivery Order SPE2DB20D2014-SPE2DB25FA85L

Award Date 1/22/25
Potential Completion Date 1/23/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA PEN 40 MG/0.8 MLS. The firm-fixed-price contract, valued at $1,213.88, has an ultimate completion date of March 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira Pen 40 mg/0.8 ml. The contract has a ceiling value of $3,537.24 and an ultimate completion date of October 20, 2022. The contract is a Firm Fixed Price agreement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Humira Pen 40 mg/0.8 mL pharmaceutical products. The single-award, firm fixed-price delivery order has a ceiling value of $3,614.75 and an ultimate completion date of May 6, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira Pen 40 mg/0.8 ml. The contract has a ceiling value of $8,428.26 and is a firm fixed-price delivery order with a completion date of July 5, 2022. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract, valued at $11,082.96, is for the supply of Humira Pen 40 mg/0.8 mls, a prescription medication. The contract has a completion date of May 22, 2024. AmerisourceBergen Drug Corporation, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Humira Pen 40 mg/0.8 mL. The contract has a firm fixed price of $3,697.18 and an ultimate completion date of August 9, 2024. The award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for $3,653.62 and covers the procurement of Humira Pen 40 mg/0.8 mLs, a specialty pharmaceutical product. The contract has an ultimate completion date of June 29, 2022 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Humira Pen 40 mg/0.8 mL, a specialty medication used to treat various medical conditions. The ceiling value of this delivery order is $7,165.07, with a firm fixed price pricing type. The contract has a period of performance through June 23, 2023. This award is not designated as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,190.32 firm fixed-price contract is for the delivery of HUMIRA PEN 40 MG/0.8 MLS, a specialty pharmaceutical. The contract has an ultimate completion date of November 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,866.56, is for the supply of Humira Pen 40 mg/0.8 mL, a specialty medication used for various medical conditions. The contract has a firm fixed price pricing type and an ultimate completion date of December 6, 2024. This award is associated with a larger Indefinite Delivery Contract...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA85L
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Humira Pen 40 mg/0.8 mL. The award is for a firm fixed price of $1,132.95 and has an ultimate completion date of January 23, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/23/25, 12:02 PM